Background Medication‐related osteonecrosis of the jaw (MRONJ) is a severe adverse
reaction experienced by some individuals to certain medicines commonly used in the …

Fibrin, derived from proteins involved in blood clotting (fibrinogen and thrombin), is a
biopolymer with different applications in the health area since it has hemostasis …

Aim: The purpose of this study was to obtain data concerning growth factor release within
liquid and solid platelet-rich fibrin (PRF) matrices and to estimate the amount of potential …

Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer.
They improve quality of survival by reducing skeletal-related events, treating …

Background and Objectives: Medication-related osteonecrosis of the jaws (MRONJ) is a
disease that affects many patients taking anti-angiogenic and antiresorptive medicines …

Introduction Medication-related osteonecrosis of the jaws (MRONJ) is a complication that
develops in patients who use or have used antiresorptive or antiangiogenic medications for …

Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating adverse effect of
bisphosphates, antiresorptive therapy or antiangiogenic agents that can potentially increase …

Background: The application of blood concentrates has gained popularity in dentistry in
recent years. Platelet-rich fibrin (PRF) has been discussed frequently due to a high content …

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that is
becoming more common in the everyday practice of both dental and maxillofacial surgeons …

Medication-Related Osteo-Necrosis of the Jaws (MRONJ) is a severe painful complication of
the long-lasting administration of bisphosphonates and anti-resorptive and anti …